EPA-0396 – Sustained efficacy and safety of agomelatine 10, 25 and 25–50mg versus placebo over 24 weeks in out-patients suffering from moderate to severe major depressive disorder

✍ Scribed by Kennedy, S.H.; Avedisova, A.; Picarel, F.; De Bodinat, C.

• Book ID: 125820788
• Publisher: Elsevier Science
• Year: 2014
• Tongue: French
• Weight: 72 KB
• Volume: 29
• Category: Article
• ISSN: 0924-9338
• DOI: 10.1016/S0924-9338(14)77819-8